Phase 2 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference11 articles.
1. Racial differences in the cause-specific prevalence of blindness in east Baltimore;Sommer;N Engl J Med,1991
2. Glaucoma
3. Current and emerging medical therapies in the treatment of glaucoma;Bagnis;Expert Opin Emerg Drugs,2011
4. Effects of Rho-associated protein kinase inhibitor, Y-27632, on intraocular pressure and outflow facility;Honjo;Invest Ophthalmol Vis Sci,2001
5. Rho-associated protein kinase inhibitor, Y-27632, induces alterations in adhesion, contraction and motility in cultured human trabecular meshwork cells;Koga;Exp Eye Res,2006
Cited by 162 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RNA-seq transcriptomic profiling of TGF-β2-exposed human trabecular meshwork explants: Advancing insights beyond conventional cell culture models;Experimental Cell Research;2024-10
2. A Narrative Review of Pharmacotherapy of Glaucoma;Future Pharmacology;2024-05-27
3. The Application of Rho Kinase Inhibitors in the Management of Glaucoma;International Journal of Molecular Sciences;2024-05-21
4. Ocular Pharmacology;The Journal of Clinical Pharmacology;2024-05-06
5. The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study;Ophthalmology and Therapy;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3